Newsroom
LATEST NEWS
Vascular Solutions To Participate In Bank Of America Merrill Lynch 2012 Health Care Conference
For Immediate Release: Tuesday, May 1, 2012
NEWS RELEASE
Contact:
James Hennen, CFO
Phil Nalbone, VP
Vascular Solutions, Inc.
(763) 656-4300
VASCULAR SOLUTIONS TO PARTICIPATE IN BANK OF AMERICA MERRILL LYNCH 2012 HEALTH CARE CONFERENCE
MINNEAPOLIS, Minnesota –Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to participate in the Bank of America Merrill Lynch 2012 Health Care Conference being held at The Encore at Wynn in Las Vegas.
James Hennen, Chief Financial Officer of Vascular Solutions, will present on Tuesday, May 15th at 5:00pm (PDT). To hear the live audio webcast of the panel discussion, go to the investor relations page of the Company’s web site http://www.vasc.com and click on the “Investor Conferences” icon a few minutes prior to start time to download any necessary software.
About Bank of America
Bank of America is among the world’s leading wealth management companies and is a global leader in corporate and investment banking and trading across a broad range of asset classes, serving corporations, governments, institutions and individuals around the world. Bank of America offers industry-leading support to approximately 4 million small business owners through a suite of innovative, easy-to-use online products and services. The company serves clients through operations in more than 40 countries. Bank of America Corporation stock (NYSE: BAC) is a component of the Dow Jones Industrial Average and is listed on the New York Stock Exchange.
About Vascular Solutions
Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company’s product line consists of over 50 products and services in three categories: catheter products, hemostat products and vein products. Vascular Solutions delivers its products and services to interventional cardiologists, interventional radiologists, electrophysiologists and vein specialists through its direct U.S. sales force and international independent distributor network.
The information in this press release contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements. Important factors that may cause such differences include those discussed in our Annual Report on Form 10-K for the year ended December 31, 2011 and other recent filings with the Securities and Exchange Commission. The risks and uncertainties include, without limitation, risks associated with the need for adoption of our new products, lack of sustained profitability, exposure to intellectual property claims, significant variability in quarterly results, exposure to possible product liability claims, the development of new products by others, doing business in international markets, the availability of third party reimbursement, and actions by the FDA.
For further information, connect to http://www.vasc.com/.